Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study

Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study

OBJECTIVE: To assess apremilast's impact on patient quality of life (QoL) in active Behçet's syndrome and correlations between improvement in patients' QoL and efficacy measures in the phase 3 RELIEF study. METHODS: QoL measures included Behçet's Disease QoL (BDQoL), 36-Item Sh...

Full description

Bibliographic Details
Main Authors: Chen, M. (Author), Cheng, S. (Author), Hatemi, G. (Author), Kim, D. (Author), Mahr, A. (Author), McCue, S. (Author), Melikoğlu, M. (Author), Paris, M. (Author), Takeno, M. (Author), Yazici, Y. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Behcet Syndrome
Patient Reported Outcome Measures
Systemic vasculitis
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items